Afternoon of the third day of the 2025 National Conference: Representatives from companies such as Novartis, Roche, and Betta Pharmaceuticals enter
According to a reporter from the Financial Associated Press, at the on-site negotiations for the 2025 National Medical Insurance Catalog and the price negotiations for the innovative drug catalog of commercial insurance, the afternoon session of the 2025 national negotiations began around 1:40 PM. Companies present included Novartis, Gensai, Roche, and Betta Pharmaceuticals. Observations from the site indicated that the focus of today's morning negotiations was on chronic disease medications, including diabetes drugs, with Eli Lilly and Yino Pharmaceutical bringing significant products to the negotiations
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments